Authors :
Dr. Saima Muhammed Nawaz; Jabin Abdulla Modatheeri; Nuzhat Nawaz
Volume/Issue :
Volume 10 - 2025, Issue 7 - July
Google Scholar :
https://tinyurl.com/53s82xnv
DOI :
https://doi.org/10.38124/ijisrt/25jul106
Note : A published paper may take 4-5 working days from the publication date to appear in PlumX Metrics, Semantic Scholar, and ResearchGate.
Note : Google Scholar may take 30 to 40 days to display the article.
Abstract :
This case study investigates the impact of Lyme neuroborreliosis (LNB) on cognitive and executive functions in a 60-
year-old pilot. Using purposive sampling, the participant’s executive function was assessed with the Delis-Kaplan Executive
Function System (D-KEFS), and memory was evaluated with the Wechsler Memory Scale (WMS). A quantitative approach
employing paired with t-tests compared to cognitive performance before and after LNB diagnosis. Results showed a
significant decline in memory function post-LNB (t (3) = 3.055, p = 0.028). Executive function also declined, particularly in
visual scanning and inhibition, although these changes were not statistically significant (t (2) = 2.079, p = 0.087). These
findings suggest that LNB may contribute to cognitive deterioration, especially in memory domains. The rapid cognitive
decline observed within six months from superior to below-average performance highlights the aggressive progression of
Lyme neuroborreliosis on cognitive function especially in memory. This swift deterioration underscores the urgent need for
early and comprehensive cognitive assessments to enable timely intervention and support. Given the study limitation of a
single participant and no control group, further research with larger samples is necessary. Comprehensive cognitive
assessments are recommended for individuals with LNB to facilitate timely intervention and support.
References :
- Berende, A., et al. (2019). Effect of prolonged antibiotic treatment on cognition in patients with Lyme borreliosis. Neurology, nineteen citations. DOI.
- Halperin, J. (2018). Diagnosis and management of Lyme neuroborreliosis. Expert Review of Anti-Infective Therapy, nineteen citations. DOI.
- Zubcevik, N., et al. (2020). Symptom Clusters and Functional Impairment in Individuals Treated for Lyme Borreliosis. Frontiers in Medicine, one citation. DOI.
- Bransfield, R. (2018). Neuropsychiatric Lyme Borreliosis: An Overview with a Focus on a Specialty Psychiatrist’s Clinical Practice. Healthcare, thirty-five citations. DOI.
- Riggle, C., et al. (2021). Implications and Aspects of Lyme Neuroborreliosis. EMJ Microbiology & Infectious Diseases, zero citations. DOI.
- Halperin, J. (2018). Neuroborreliosis and Neurosyphilis. Continuum, twenty citations. DOI.
- Garkowski, A., et al. (2020). Imaging of Lyme Neuroborreliosis: A Pictorial Review. Open Forum Infectious Diseases, five citations. PDF. DOI.
- Dersch, R., et al. (2015). Prevalence and spectrum of residual symptoms in Lyme neuroborreliosis after pharmacological treatment: a systematic review. Journal of Neurology, forty-nine citations. DOI.
- Petridou, C., et al. (2020). A retrospective observational study of Lyme neuroborreliosis in the southwest of England. DOI
- Marques, A. (2015). Lyme Neuroborreliosis. Continuum, three citations. DOI
- Xing, J., et al. (2015). Cerebrospinal Fluid Cytology of Lyme Neuroborreliosis: A Report of 3 Cases with Literature Review. Acta Cytologica, eight citations. DOI
- Dessau, R. B., et al. (2018). To test or not to test? Laboratory support for the diagnosis of Lyme borreliosis: a position paper of ESGBOR, the ESCMID study group for Lyme borreliosis. Clinical microbiology and infection: the official publication of the European Society of Clinical Microbiology and Infectious Diseases, sixty-eight citations. DOI
- Koedel, U., et al. (2017). Lyme neuroborreliosis. Current Opinion in Infectious Diseases, twenty-nine citations. DOI
- García-Moncó, J., et al. (2018). Lyme Neuroborreliosis: Clinical Outcomes, Controversy, Pathogenesis, and Polymicrobial Infections. Annals of Neurology, fifty-one citations. DOI
- Cadavid, D., et al. (2016). Antibiotics for the neurological complications of Lyme disease. Cochrane Database of Systematic Reviews, thirty citations. DOI
- Guedj, E., Eldin, C., Prades, C., Debarbieux, S., & Raoult, D. (2019). Functional neuroimaging in patients presenting with somatoform disorders: A model for investigating persisting symptoms after tick bites and post-treatment Lyme disease syndrome? Medecine et maladies infectieuses, 49(3), 155-162.
- Roos, K. (2021). Neurologic Complications of Lyme disease. Continuum, 27(4), 936-958.
- Rosenblat, J. D., McIntyre, R. S., Alves, G. S., Fountoulakis, K. N., Carvalho, A. F., & Berk, M. (2015). Inflammation as a neurobiological substrate of cognitive impairment in bipolar disorder: Evidence, pathophysiology, and treatment implications. Journal of affective disorders, 188, 149-159.
- Ortiz-Guerrero, G., Siemann, D. N., & Choromanski, L. J. (2020). Pathophysiological Mechanisms of Cognitive Impairment and Neurodegeneration by Toxoplasma gondii Infection. Brain Sciences, 10(4), 233.
- Dersch, R., Sommer, H., Rauer, S., & Meerpohl, J. J. (2016). Efficacy and safety of pharmacological treatments for Lyme neuroborreliosis in children: a systematic review. BMC Neurology, 16(1), 1-13.
- Zajkowska, J., Garkowski, A., & Moniuszko, A. (2015). Vasculitis and stroke due to Lyme neuroborreliosis–a review. Infectious Diseases, 47(1), 1-6.
- Stinco, G., & Zeleníková, J. (2016). Impact of Co-Infections in Lyme disease. Wiener klinische Wochenschrift, 128(19-20), 715-722.
- Mackay, M., & Buss, S. (2015). Lupus brain fog: a biologic perspective on cognitive impairment, depression, and fatigue in systemic lupus erythematosus. Immunologic Research, 63(1-3), 26-37.
- Rauer, S., et al. (2020). Guidelines for diagnosis and treatment in neurology–Lyme neuroborreliosis. German medical science: GMS e-journal, 18.
- Lin, Y. P., & Marques, A. R. (2017). Borrelia burgdorferi glycosaminoglycan-binding proteins: a potential target for new therapeutics against Lyme disease. Microbiology, 163(10), 1428-1437.
- Summer, G., & Halperin, J. (2019). Neurologic manifestations of Lyme Borreliosis. Revue neurologique, 175(6), 367-370.
- Azzolino, S., Patruno, A., Bottaro, L. C., & Corsello, S. M. (2019). The prevalence of Lyme disease and associated co-infections in people with a chronic post-concussive syndrome. Psychiatria Danubina, 31(3), 320-325.
This case study investigates the impact of Lyme neuroborreliosis (LNB) on cognitive and executive functions in a 60-
year-old pilot. Using purposive sampling, the participant’s executive function was assessed with the Delis-Kaplan Executive
Function System (D-KEFS), and memory was evaluated with the Wechsler Memory Scale (WMS). A quantitative approach
employing paired with t-tests compared to cognitive performance before and after LNB diagnosis. Results showed a
significant decline in memory function post-LNB (t (3) = 3.055, p = 0.028). Executive function also declined, particularly in
visual scanning and inhibition, although these changes were not statistically significant (t (2) = 2.079, p = 0.087). These
findings suggest that LNB may contribute to cognitive deterioration, especially in memory domains. The rapid cognitive
decline observed within six months from superior to below-average performance highlights the aggressive progression of
Lyme neuroborreliosis on cognitive function especially in memory. This swift deterioration underscores the urgent need for
early and comprehensive cognitive assessments to enable timely intervention and support. Given the study limitation of a
single participant and no control group, further research with larger samples is necessary. Comprehensive cognitive
assessments are recommended for individuals with LNB to facilitate timely intervention and support.